The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Development of life-expectancy tables for people with type 2 diabetes
Open accessAbstract
AIMS: To develop tables that report the life expectancy associated with levels of major modifiable risk factors for patients with type 2 diabetes. METHODS AND RESULTS: A set of tables reporting life-expectancy stratified by age-sex groups for combinations of modifiable risk was constructed based on predictions from the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model. This model is based on a system of parametric proportional hazards risk equations for estimating mortality and vascular complications of diabetes that have been estimated from 3642 patients from the UKPDS. The tables show substantial potential gains in life expectancy within every age group from modifying major risk factors. The estimated life expectancy of men at age of 55 years with type 2 diabetes, 5 years after diagnosis, varies between 13.2 years for a patient who smokes, has systolic blood pressure of 180 mmHg, a total:HDL cholesterol ratio of 8, and HbA(1c) of 10%, and 21.1 years for a non-smoker with SBP of 120 mmHg, total/HDL ratio of 4, and HbA(1c) of 6%. CONCLUSION: Life expectancy tables provide a potentially useful tool of conveying prognostic information to people with type 2 diabetes and suggest substantial scope for increasing longevity by improving modifiable risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cardiovascular disease (CVD) accounts for 75% of all related deaths in diabetic patients and on average individuals with T2D have an increased risk of shorter life expectancy.44,45”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [45]
In the citing paper
“By contrast, the UKPDS-OM2 takes a completely transparent approach [6, 26], in which we have fully reported its development, the equations that determine all outcomes and the algorithm used to bring the elements of the model together.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
The J-Curve Phenomenon in Hypertension
Kang, Y., & Wang, J. (2016) · Pulse · doi:10.1159/000446922 · Cited by 1,551
Lifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515
Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971–1993
Gu, K., Cowie, C. C., & Harris, M. I. (1998) · Diabetes Care · doi:10.2337/diacare.21.7.1138 · Cited by 881
Lipkus, I. M. (2007) · Medical Decision Making · doi:10.1177/0272989x07307271 · Cited by 796
Hyperglycemia and cardiovascular disease in type 2 diabetes.
Laakso, M. (1999) · Diabetes · doi:10.2337/diabetes.48.5.937 · Cited by 745
Heisler, M., Bouknight, R. R., Hayward, R. A., Smith, D. M., & Kerr, E. A. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.10905.x · Cited by 717
Communicating Evidence for Participatory Decision Making
Epstein, R. M. (2004) · JAMA · doi:10.1001/jama.291.19.2359 · Cited by 626
Clarke, P. M., Gray, A. M., Briggs, A., Farmer, A. J., Fenn, P., Stevens, R. J., Matthews, D. R., Stratton, I. M., Holman, R. R., & on behalf of the UK Prospective Diabetes Study (UKPDS) Group (2004) · Diabetologia · doi:10.1007/s00125-004-1527-z · Cited by 615
Self-citationFarmer, A., Wade, A., Goyder, E., Yudkin, P., French, D., Craven, A., Holman, R., Kinmonth, A.-L., & Neil, A. (2007) · BMJ · doi:10.1136/bmj.39247.447431.be · Cited by 407
Gains in Life Expectancy from Medical Interventions — Standardizing Data on Outcomes
Wright, J. C., & Weinstein, M. C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390606 · Cited by 334
A systematic review on communicating with patients about evidence
Trevena, L. J., BPsych, H. M. D., Barratt, A. L., Butow, P. N., & Caldwell, P. H. Y. (2005) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2005.00596.x · Cited by 329
Roper, N. A., Bilous, R. W., Kelly, W. F., Unwin, N. C., & Connolly, V. M. (2001) · BMJ · doi:10.1136/bmj.322.7299.1389 · Cited by 316
Computer Modeling of Diabetes and Its Complications
The Mount Hood 4 Modeling Group (2007) · Diabetes Care · doi:10.2337/dc07-9919 · Cited by 243
Updated New Zealand cardiovascular disease risk-benefit prediction guide
Jackson, R. (2000) · BMJ · doi:10.1136/bmj.320.7236.709 · Cited by 229
Prediction of first coronary events with the Framingham score: A systematic review
Eichler, K., Puhan, M. A., Steurer, J., & Bachmann, L. M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.02.027 · Cited by 219
The Progressive Cost of Complications in Type 2 Diabetes Mellitus
Brown, J. B., Pedula, K. L., & Bakst, A. W. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.16.1873 · Cited by 216
Coleman, R. L., Stevens, R., Retnakaran, R. R., & Holman, R. R. (2007) · Diabetes Care · doi:10.2337/dc06-1358 · Cited by 192
Edwards, A. (2004) · Family Practice · doi:10.1093/fampra/cmh402 · Cited by 179
Sheridan, S., Pignone, M., & Mulrow, C. (2003) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2003.30107.x · Cited by 178
The FIELD Study Investigators (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-13 · Cited by 103
Different Ways to Describe the Benefits of Risk-Reducing Treatments
Halvorsen, P. A., Selmer, R. M., & Kristiansen, I. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00006 · Cited by 79
Dale, A. C., Nilsen, T. I. L., Vatten, L. J., Midthjell, K., & Wiseth, R. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm447 · Cited by 67
ADVANCE Collaborative Group (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01596.x · Cited by 62
Predicting CHD risk in patients with diabetes mellitus
Yeo, W. W., & Yeo, W. W. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00510.x · Cited by 61
Novel geometric ordering of ferroelectricity
Scott, J. F. (2005) · Nature Materials · doi:10.1038/nmat1287 · Cited by 54
Christensen, P. M. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80318-1 · Cited by 42
Dahl, R., Gyrd‐Hansen, D., Kristiansen, I. S., Nexøe, J., & Nielsen, J. B. (2007) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-7-8 · Cited by 30
Holman, R. R., Retnakaran, R. R., Farmer, A. A., & Stevens, R. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67914-2 · Cited by 30
Holman, R. R., Retnakaran, R. R., Farmer, A. W., & Stevens, R. H. (2006) · The Lancet · Cited by 28
How long do people expect to live? Results and implications
O’Brien, C., Fenn, P., & Diacon, S. R. (2005) · Cited by 26
Thomason, M. J., Colhoun, H. M., Livingstone, S. J., Mackness, M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., Neil, H. A. W., Fuller, J., & the CARDS Investigators (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01401.x · Cited by 22
Research works printed but not linked: 1
- 1995, Mortality in non-insulin-dependent diabetes, 233
Cited by
Sorted by citations
Authors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,994
Li, Y., Schoufour, J. D., Wang, D. D., Dhana, K., Pan, A., Liu, X., Song, M., Liu, G., Shin, H. J., Sun, Q., et al. (2020) · BMJ · doi:10.1136/bmj.l6669 · Cited by 698
Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., Huikuri, H., et al. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Hayes, A. J., Leal, J., Gray, A. M., Holman, R. R., & Clarke, P. M. (2013) · Diabetologia · doi:10.1007/s00125-013-2940-y · Cited by 495
Self-citationReed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Metadata
- Authors
- Leal, J., Gray, A. M., & Clarke, P. M.
- Affiliations
- University of Oxford (GB)
- The University of Sydney (AU)
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-12-24
- Volume
- 30
- Issue
- 7
- Pages
- 834-839
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- PMC
- PMC2663724
- OpenAlex
- W2107098508
- Cited by
- 128
- References
- 40
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 2 · 2023: 2 · 2022: 9 · 2021: 12 · 2020: 11 · 2019: 12 · 2018: 5 · 2017: 8 · 2016: 12 · 2015: 7 · 2014: 13 · 2013: 12 · 2012: 3
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Diabetes Australia
- Medical Research Council
- National Health and Medical Research Council (512463)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, life expectancy, modifiable risk factors, mortality prediction, vascular complications, smoking, systolic blood pressure, TC/HDL-C ratio, HbA1c, prognosis
- MeSH terms
- Aged, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, United Kingdom, Health Status, Health Surveys, Humans, Life Expectancy, Male, Middle Aged, Prognosis, Prospective Studies, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
